No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US ETFDetailed Quotes
XBI SPDR S&P Biotech ETF
- 91.280
- +1.470+1.64%
Close Dec 20 16:00 ET
91.970High89.340Low
91.970High89.340Low10.34MVolume89.370Open89.810Pre Close942.37MTurnover14.97%Turnover Ratio--P/E (Static)69.05MShares105.47052wk High--P/B6.30BFloat Cap81.02652wk Low0.13Dividend TTM69.05MShs Float174.461Historical High0.14%Div YieldTTM2.93%Amplitude21.348Historical Low91.156Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
SPDR S&P Biotech ETF To Go Ex-Dividend On December 23rd, 2024 With 0.00269 USD Dividend Per Share
December 20th (Eastern Time) - $SPDR S&P Biotech ETF(XBI.US)$ is trading ex-dividend on December 23rd, 2024.Shareholders of record on December 23rd, 2024 will receive 0.00269 USD dividend per share
Sarepta Awarded $115.2M in Vyondys 53 Patent Case: Report
Needham Reiterates Hold on Neurocrine Biosciencesto Hold
Neurocrine Biosciences Analyst Ratings
Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership
The Analyst Verdict: Incyte In The Eyes Of 15 Experts